Radouane Niamane

Marrakesh, Morocco

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Incidence and Clinical Characteristics of Herpes Zoster in Patients With Spondyloarthritis Receiving Biologic Therapy: A 36-Month Multicenter Registry-Based Study.

Incidence and Clinical Characteristics of Herpes Zoster in Patients With Spondyloarthritis Receiving Biologic Therapy: A 36-Month Multicenter Registry-Based Study.

Journal: Cureus

Published: June 15, 2026

Contribution of Trabecular Bone Score to Fracture Risk Stratification Beyond Bone Mineral Density in Women with Rheumatoid Arthritis: Results from a Cross-Sectional Cohort.

Contribution of Trabecular Bone Score to Fracture Risk Stratification Beyond Bone Mineral Density in Women with Rheumatoid Arthritis: Results from a Cross-Sectional Cohort.

Journal: Mediterranean journal of rheumatology

Published: July 23, 2025

Moroccan national guidelines for the management of postmenopausal osteoporosis.

Moroccan national guidelines for the management of postmenopausal osteoporosis.

Journal: Archives of osteoporosis

Published: July 21, 2025

Factors Determining the Switch of the First Biological Treatment in Spondyloarthritis: Data from the RBSMR Registry.

Factors Determining the Switch of the First Biological Treatment in Spondyloarthritis: Data from the RBSMR Registry.

Journal: Current rheumatology reviews

Published: April 21, 2025

Real-world evidence of biological treatments in rheumatoid arthritis and spondyloarthritis in Morocco: results of the RBSMR registry.

Real-world evidence of biological treatments in rheumatoid arthritis and spondyloarthritis in Morocco: results of the RBSMR registry.

Journal: BMC rheumatology

Published: August 07, 2024

Tumour Necrosis Factor α Inhibitors during Spondylarthritis: Therapeutic Maintenance, Reasons, and Predictive Factors of Discontinuation (Data from RBSMR Registry).

Tumour Necrosis Factor α Inhibitors during Spondylarthritis: Therapeutic Maintenance, Reasons, and Predictive Factors of Discontinuation (Data from RBSMR Registry).

Journal: Mediterranean journal of rheumatology

Published: December 27, 2023

Prevalence of postmenopausal osteoporosis in Morocco: a systematic review and meta-analysis.

Prevalence of postmenopausal osteoporosis in Morocco: a systematic review and meta-analysis.

Journal: Archives of osteoporosis

Published: December 20, 2023

Active tuberculosis infection in moroccan patients with rheumatic diseases under biologic therapy: A multicenter national study.

Active tuberculosis infection in moroccan patients with rheumatic diseases under biologic therapy: A multicenter national study.

Journal: International journal of mycobacteriology

Published: July 01, 2022

Discontinuation of biologic therapy in patients with rheumatoid arthritis and ankylosing spondylitis: analysis from multicenter cohort study.

Discontinuation of biologic therapy in patients with rheumatoid arthritis and ankylosing spondylitis: analysis from multicenter cohort study.

Journal: Rheumatology international

Published: June 07, 2022

Telehealth in rheumatology: the 2021 Arab League of Rheumatology Best Practice Guidelines.

Telehealth in rheumatology: the 2021 Arab League of Rheumatology Best Practice Guidelines.

Journal: Rheumatology international

Published: October 30, 2021

Therapeutic Maintenance Level of Methotrexate in Rheumatoid Arthritis: A RBSMR Study.

Therapeutic Maintenance Level of Methotrexate in Rheumatoid Arthritis: A RBSMR Study.

Journal: Mediterranean journal of rheumatology

Published: June 13, 2021

One-year direct costs of biological therapy in rheumatoid arthritis and its predictive factors: data from the Moroccan RBSMR registry.

One-year direct costs of biological therapy in rheumatoid arthritis and its predictive factors: data from the Moroccan RBSMR registry.

Journal: Rheumatology international

Published: October 12, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026